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assay inaccuracies, the subsequent reanalysis, and
results of the reanalysis were imperative to communicate
to the medical community.
Appendix A. Supplementary data
Supplementary data associated with this article can
be found, in the online version, at doi:10.1016/j.jhep.
2008.05.009.
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Spanish reports of hepatotoxicity associated with Herbalife products
To the Editor:
We have read with interest the articles recently pub-
lished in this journal by Elinav et al. [1] and Schoepfer
et al. [2], as well as the editorial by Stickel [3], reporting
and discussing two series of cases from Israel and Swit-
zerland of hepatotoxicity associated with the consump-
tion of Herbalife slimming products. Stickel [3] raises
the question of why products which are distributed in
at least 60 countries only seem to induce hepatotoxicity
in two.
In Spain, as perhaps in other countries, Herbalife
distributes its products through door-to-door salesmen
and the internet. Some products are registered as dietetic
supplements, but others are not registered at all. In
2005, three cases of hepatotoxicity (two hepatitis and
one of increased liver enzymes) were reported to the
Pharmacovigilance Centre of Asturias, an area in the
north of Spain. Another case of increased liver enzymes
was reported in 2006. All the four cases occurred in wo-
men between 47 and 57 years old, and all came from the
same hospital. Three of these were published last Febru-
ary in a Spanish medical journal [4].
In the two cases of hepatitis the patients were sisters.
One of whom developed severe liver damage. After tak-
ing Herbalife products for 1 year and losing 20 kg in
weight, she was referred to hospital suﬀering from wide-
spread pruritus, jaundice, fatigue and abdominal strain.
Biochemical tests showed liver transaminases over
1000 U/l and 12 mg/dl of total bilirubin. Test antibodies
to hepatitis were negative. Abdominal ultrasound
showed a cholelithiasis that was surgically removed.
Although she was recommended to cease taking Herba-
life products, she continued to do so for another 2
years and developed chronic liver disease with recurrent
exacerbations. Liver biopsy showed acute hepatitis
grade 4 on chronic liver disease stage 3. She was diag-
nosed as having idiopathic or toxic autoimmune hepati-
tis, and is currently being treated with corticosteroids.
Her sister took Herbalife products for six months
and developed diarrhea, hyperbilirubinemia, jaundice
and pruritus. Biochemical tests showed transaminases
over 1000 U/l and 26.7 mg/dl of total bilirubin. Viral
antibodies were negative. Subacute cholestatic hepatitis
was diagnosed and the withdrawal of Herbalife prod-
ucts was recommended. Some months later, the patient
had totally recovered. The two sisters took the following
Herbalife products: formulas 1, 2, 3 and 4, RoseOx,
Herbalifeline, Guarana´, Classic Aromatized Tea and
Herbal Aloe.
The patients in the other two cases of reported hepa-
totoxicity were also taking Herbalife products over a
period of 1 month in one case and 3 years in the other,
and developed increased transaminases which were de-
tected on routine analysis. After the withdrawal of Her-
balife products, the enzyme levels returned to normal.
To explain the mechanism involved in the hepatotox-
icity induced by Herbalife products, Elinav et al. [1]
have suggested genetic susceptibility to develop an im-
mune-mediated liver toxicity associated with one or
more constituents. The family ties between the two cases
of hepatitis reported in Spain and the diagnosis of auto-
immune hepatitis in one case support this observation.
We agree with Stickel [3] when he explains that it is ex-
tremely diﬃcult to identify the crucial compounds when
consumers of Herbalife are taking several products.
Although toxic or bacteriological contamination of
some batches cannot be dismissed, we believe that some
components of Herbalife products could be the hepa-
toxicity inducers. Firstly, as Schoepfer et al. [2] have
suggested, the green tea contained in the Classic Aroma-
tized Tea and also in other Herbalife products. In the
last 5 years, evidence on the ability of green tea to induce
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liver damage has increased [5,6]. In April 2003, the
Spanish Agency of Medicine and Health Products with-
drew the over the counter medicine Exolise from the
market. This contained an ethanolic extract of green
tea, and was the cause of four cases of hepatotoxicity
in Spain [7] and nine in France [8]. In none of the Her-
balife products containing green tea is the type of ex-
tract or the amount of active substances speciﬁed. On
the other hand, several authors [9–11] have reported
cases of acute hepatitis associated with the consumption
of Aloe vera tablets or capsules. Aloe vera is the main
component of the drink Herbal Aloe sold by Herbalife.
We do not believe that the hepatotoxicity of the Her-
balife products is conﬁned to three countries alone.
The lower use in some areas, the underreporting of ad-
verse reactions, and the lower ability to detect or report
information in the international scientiﬁc media could
be the reasons for explaining this lack of information
from other countries. For some time, Latin American
and Spanish health professionals have been discussing
the safety of Herbalife products and similar com-
pounds on internet forums.
Schoepfer et al. [2] and Stickel [3] consider that the
hepatotoxicity associated with Herbalife products does
not seem to be a threat to public health and have sug-
gested an incidence lower than that of the non-steroidal
anti-inﬂammatory drugs. In our opinion, the evaluation
of this safety problem is impossible because we have no
precise consumption data nor isolated active substances
of established eﬃcacy. Perhaps the hepatotoxicity we are
speaking about is of low incidence and aﬀects patients
with genetic susceptibility or other risk factors. How-
ever, the growing consumption of products promoted
as ‘‘natural”, without deﬁned composition, quality con-
trol and demonstrated activity and safety is a real health
problem that should be kept under control. Today we
are speaking only about the products of the Herbalife
brand, but tomorrow we may be speaking about other
products or other brands.
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More reports of potential hepatotoxicity of Herbalife products: Reply
To the Editor:
The Letter to the Editor by Manso and colleagues
from Spain [1] reiterates the deep concern recently raised
[2–4] regarding the potential hepatotoxicity of one or
more HerbalifeTM products. This report adds 4 more
patients to the already described 22 patients from two
countries, who developed a variable degree of liver
injury in association with the intake of HerbalifeTM
products.
Two of the Spanish patients developed quite severe
hepatitis with jaundice and 3/4 recovered after stopping
intake of the products. Although the information pro-
vided is not complete, causality may be established in
at least two cases as probable and in the remaining
two cases as possible, based on the same criteria as re-
ported in Ref. [2–4].The development of hepatitis in
two sisters, one of whom has or progressed to chronic
hepatitis, is an important observation which may shed
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